BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Career Advice

  13 Time Management Strategies for Effective Professionals

  Are you feeling that your productivity is decreasing at work? Here are some beneficial time management strategies to be mindful of to get work done efficiently.

  June 17, 2021

   · 

  4 min read

   · 

  Lorenzo Soliman
• 

  Business

  BioSpace Movers & Shakers, June 18

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  June 17, 2021

   · 

  9 min read

   · 

  Alex Keown
• 

  BioMidwest

  Tumors Next Target for T Cell Therapies with U Minnesota Research

  New research shows T cells can be engineered to migrate more effectively inside tumor microenvironments, raising hopes of reproducing the remarkable outcomes seen for certain hematological cancer patient subsets in broader populations and indications.

  June 17, 2021

   · 

  4 min read

   · 

  Mark Zipkin
• 

  Deals

  Danaher Expands Life Sciences Segment with $9.6 Billion Buy

  Global science and technology innovator Danaher Corporation is adding another company to its ever-growing global operation.

  June 17, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  Inside ReCode’s New-in-Class Approach to Treating Cystic Fibrosis

  The data showed that both experimental therapies restored function in the cystic fibrosis transmembrane conductance regulator gene.

  June 17, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Deals

  Push to Public Continues as Biotech Dominates the IPO List This Week

  Biotech companies are dominating Nasdaq’s IPO scheduled this week. Here’s who is making their big public debut.

  June 17, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Policy

  Recent Studies, Reports Call for Further Probe Into COVID-19 Origins

  Scientists call for more investigation into the origin of the virus, particularly in China, but China now wants to include the U.S. in the probe.

  June 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  FDA

  Rare Blood Disease Drug Ayvakit’s Win Marks Fourth Approval for Blueprint Medicines

  The U.S. FDA approved Ayvakit for the treatment of adult patients with advanced sytematic mastocytosis (SM), advanced SM, and mast cell leukemia.

  June 17, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Novartis Scores Breakthrough Therapy Designation to Speed Prostate Cancer Drug Approval

  The FDA granted it to Lu-PSMA-617, an investigational radioligand therapy to treat metastatic castration-resistant prostate cancer.

  June 17, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  How Cancer Fools the Immune System Into Developing the Disease

  Research shows that cancer can fool immune cells, which normally repair the body, into actually helping develop the disease.

  June 17, 2021

   · 

  2 min read

   · 

  Alex Keown